BioAdaptives Inc.
OTC: BDPT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- James Keener
- Employees
- 1
- Headquarters
- Las Vegas, United States
- IPO year
- 2016
- Market cap
- $47.0K
- Website
- https://www.shopbioadaptives.com
Loading BDPT…
Loading profile data…Frequently asked questions about BDPT
What does BioAdaptives Inc. (BDPT) do?
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability...
Where does BDPT trade?
BioAdaptives Inc. (BDPT) trades on the Other OTC.
What sector is BDPT in?
BioAdaptives Inc. (BDPT) operates in the Consumer Defensive sector, specifically in the Packaged Foods industry.
Who is the CEO of BioAdaptives Inc.?
James Keener is the chief executive officer of BioAdaptives Inc. (BDPT).
Where is BioAdaptives Inc. headquartered?
BioAdaptives Inc. is headquartered in United States.
Does BDPT pay a dividend?
BioAdaptives Inc. (BDPT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BDPT go public?
BioAdaptives Inc. (BDPT) completed its initial public offering in 2016.